Real-World Safety and Effectiveness of Ganirelix for Ovarian Stimulation in Chinese Women: A Multicenter, Prospective, Single-Arm, Observational Study
This study indicates that the safety profile and effectiveness of ganirelix were clinically acceptable, and no new safety signals emerged in real-world clinical practice for Chinese women with OS. The study was registered on Chinadrugtrial.org (identifier: CTR20150284) (http://www.chinadrugtrials.org.cn) and ENCePP.eu (identifier: EUPAS8737) (https://catalogues.ema.europa.eu).
Authors
- Yong Zeng (ORCID: https://orcid.org/0000-0002-6264-283X)
- Fei Gong (ORCID: https://orcid.org/0000-0002-7474-0680)
- Zhaolian Wei (ORCID: https://orcid.org/0000-0001-8474-7272)
- Sisi Chen (ORCID: https://orcid.org/0000-0002-3468-5891)
- Rui Yang (ORCID: https://orcid.org/0000-0003-3530-9115)
- Jianqiao Liu (ORCID: https://orcid.org/0000-0002-4061-3333)
- Xiaohong Wang (ORCID: https://orcid.org/0000-0001-8925-5736)
- Jue Wang (ORCID: https://orcid.org/0000-0001-6118-880X)
- Jia Li (ORCID: https://orcid.org/0000-0003-3224-001X)
- Lihong Geng
- Keith Gordon
- Rong Li (ORCID: https://orcid.org/0000-0003-0587-8130)
Institutions
- Anhui Medical University (CN)
- Peking University (CN)
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- Reproductive & Genetic Hospital CITIC-Xiangya (CN)
- SNV Netherlands Development Organisation (NL)
- Shanghai Institute of Organic Chemistry (CN)
- Chengdu University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Peking University Third Hospital (CN)
- Tang Du Hospital (CN)
- Shenzhen Zhongshan Urological Hospital (CN)
- Organogenesis (United States) (US)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Women s Health Reports
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1177/26884844251387017
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00